Clinical UpdatesDrug News

An existing anti-stroke drug is an effective treatment for middle-ear infections, showing the ability to suppress mucus overproduction, improve bacterial… »   

The drug dasabuvir (trade name Exviera) has been available since January 2015 for the treatment of adults with chronic hepatitis… »   

A new study finds that effective new hepatitis C drugs are so expensive the state of Rhode Island would have… »   

A new statistical analysis suggests that, in the short term, the Mexican government’s war against drugs increased the average murder… »   

A discrepancy exists between the ethical standard codified in the pharmaceutical industry Codes of Practice and the actual conduct of… »   

German drugmaker Bayer AG is exploring the sale of its $10 billion plastics unit to focus on growing its health… »   

Actavis Plc said on Monday it has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive… »   

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may… »   

Johnson & Johnson said on Friday it was ending its efforts to bring to market a rival drug to Allergan… »   

Texas is reconsidering whether to impose strict limits on Gilead Sciences’ $84,000 hepatitis C treatment for patients on the… »   

The U.S. Food and Drug Administration has denied an appeal by Sprout Pharmaceuticals to approve its experimental drug for… »   

CVS Caremark Corp said on Friday that the Centers for Medicare and Medicaid Services lifted sanctions it had imposed earlier… »   

Bristol-Myers Squibb Co is close to selling its stake in a diabetes partnership with AstraZeneca Plc to the British drugmaker… »   

The drug saxagliptin (trade name: Onglyza) has been approved also as monotherapy in Germany since July 2013 for certain adults… »   

Shares of OncoMed Pharmaceuticals Inc more than doubled on Tuesday after the biotechnology company said Celgene Corp would help it… »